QIAGEN Reports Results for Fourth Quarter and Full-Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street dips after strong jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil slides on Friday, heads for weekly gain on US-Iran fight
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Qiagen (QGEN) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus
February 4, 2020 4:15 PM ESTQiagen (NYSE: QGEN) reported Q4 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $413.5 million versus the consensus estimate of $408.58 million.
Delivers on Q4 2019 net sales outlook, exceeds on adjusted EPSNet sales of $413.5 million (+3% actual, +4% CER, vs. ~+3% CER outlook)Diluted EPS $0.19; adjusted EPS $0.48 ($0.48 CER, +20% CER vs. ~$0.45-0.46 CER outlook)Adjusted operating income margin rises to 33.5% of sales vs. 29.6% in Q4 2018Achieves FY 2019 net sales outlook, exceeds on adjusted EPSNet sales of $1.53 billion (+2% actual, +4% CER, vs. ~+4% CER outlook)Net loss per... More
